Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Chronic Spontaneous Urticaria (CSU) Patients
- First Posted Date
- 2020-06-19
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Stero Biotechs Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT04439955
- Locations
- 🇮🇱
Meir Medical Center, Kfar Saba, Israel
A Phase 2a Study to Evaluate the Safety and Efficacy of Cannabidiol Only as Maintenance Therapy and Steroid Sparing in Patients With Stable Autoimmune Hepatitis
- First Posted Date
- 2019-10-16
- Last Posted Date
- 2020-06-16
- Lead Sponsor
- Stero Biotechs Ltd.
- Target Recruit Count
- 2
- Registration Number
- NCT04129489
- Locations
- 🇮🇱
Belinson Medical Center, Petach Tikva, Israel
A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients
Phase 2
Completed
- Conditions
- Steroid Dependent Crohn's Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-08-14
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Stero Biotechs Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT04056442
- Locations
- 🇮🇱
Soroka Medical Center, Beer Sheva, Israel
🇮🇱Meir Medical Center, Kfar Saba, Israel
🇮🇱Shamir Medical Center, Tzrifin, Israel
News
No news found